CYCLOOCTA[B]PYRIDINE, 2-(4-ETHYL-1-PIPERAZINYL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDRO- [ 132810-10-7 ]

This product of serotonin and dopamine antagonists (SDA), is the second-generation atypical antipsychotic drugs, with a 52.4% haloperidol quite dopamine D2 receptor blocking effect, also for 5 - HT2A has the strong blocking function, to two receptor selective than other antipsychotic stronger. Than market existing antipsychotic extrapyramidal side effects less responsive. By Japanese sumitomo pharmaceutical Co., LTD develop listed. Launch date: April 2008 list in Japan.